Neuroprotection in a novel mouse model of multiple sclerosis.
Multiple sclerosis is an immune-mediated, demyelinating and neurodegenerative disease that currently lacks any neuroprotective treatments. Innovative neuroprotective trial designs are required to hasten the translational process of drug development. An ideal target to monitor the efficacy of strateg...
Guardado en:
Autores principales: | Katie Lidster, Samuel J Jackson, Zubair Ahmed, Peter Munro, Pete Coffey, Gavin Giovannoni, Mark D Baker, David Baker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25c87925b0f24c17a681f38b45d83852 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic regions associated with multiple sclerosis are active in B cells.
por: Giulio Disanto, et al.
Publicado: (2012) -
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
por: Luca Muzio, et al.
Publicado: (2020) -
Measuring treatment response to advance precision medicine for multiple sclerosis
por: Peter A. Calabresi, et al.
Publicado: (2021) -
Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1G93A mouse model of amyotrophic lateral sclerosis
por: Qinming Zhou, et al.
Publicado: (2018) -
Effects of Exercise Training on Neurotrophic Factors and Subsequent Neuroprotection in Persons with Multiple Sclerosis—A Systematic Review and Meta-Analysis
por: Mette D. Diechmann, et al.
Publicado: (2021)